Polycystic Ovarian Syndrome: Current Situation of Female Hormonal Disorder

Abstract

Aim: This study aims to describe the various concerns and treatment strategies associated with the polycystic ovarian syndrome. Polycystic syndrome of ovaries is the most prevalent endocrine problem in adult women and is distinguished by anovulation, excess androgen, and the involvement of ultrasound polycystic ovaries. Hirsutism, obesity, miscarriage, and menstrual irregularities are the signs that are particularly troubling for patients. The hypothesis describes that PCOS is a systemic disease reinforced by recent discoveries amplifying hormones and cytokines in muscle mass tissue. Result and discussion: The treatment strategy should be adapted to the patient's phenotype, problems, and willingness to replicate. Infertility care centers on treatments for activation of ovulation and may include medications, such as metformin, letrozole, clomiphene, and gonadotropin. The application of oral contraception and the adjuvant application of anti-androgens also includes the management of hirsutism. For both treatments of infertility and long-term management, weight loss in obese women with PCOS can be helpful. Conclusion: The literature survey concluded that the proper diagnosis and treatment of PCOS are important; otherwise, it cannot be adequately controlled and can cause many metabolic disorders and other health-related risks.